Is MDNA or RYLD a better dividend investment in 2026?

MDNA currently yields 1273.89% with a 5% 5-year dividend growth rate. RYLD yields 4.00% with 5% growth. The better choice depends on your goal: MDNA offers higher current income.

What is the dividend yield difference between MDNA and RYLD?

MDNA has a forward dividend yield of 1273.89% ($2.00/share annually). RYLD yields 4.00% ($2.00/share annually). The yield gap is 1269.89 percentage points.

Home › Compare › MDNA vs RYLD

MDNA vs RYLD: Dividend Comparison 2026

MDNA yields 1273.89% · RYLD yields 4.00%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 MDNA wins by $160323633.73M in total portfolio value

INVESTMENT

TIME HORIZON10 years

MDNA

● Live price

1273.89%

Share price

$0.16

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$160323633.76M

Annual income

$138,877,914,359,413.77

Full MDNA calculator →

RYLD

● Live price

4.00%

Share price

$50.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$28.0K

Annual income

$899.19

Full RYLD calculator →

Portfolio growth — MDNA vs RYLD

📍 MDNA pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	MDNA	RYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, MDNA + RYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

MDNA pays

RYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MDNA

Annual income on $10K today (after 15% tax)

$108,280.25/yr

After 10yr DRIP, annual income (after tax)

$118,046,227,205,501.70/yr

RYLD

Annual income on $10K today (after 15% tax)

$340.00/yr

After 10yr DRIP, annual income (after tax)

$764.31/yr

At 15% tax rate, MDNA beats the other by $118,046,227,204,737.39/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MDNA + RYLD for your $10,000?

MDNA: 50%RYLD: 50%

100% RYLD50/50100% MDNA

Portfolio after 10yr

$80161816.89M

Annual income

$69,438,957,180,156.48/yr

Blended yield

86.62%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MDNA right now

MDNA

Analyst Ratings

Buy

Consensus: Buy

Altman Z

-4.1

Piotroski

1/9

RYLD

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MDNA buys

RYLD buys

No recent congressional trades found for MDNA or RYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricMDNARYLD

Forward yield	1273.89% ✓	4.00%
Annual dividend / share	$2.00	$2.00
Payout ratio	50%	50%
1-year div growth	0%	5% ✓
5-year div CAGR	0%	5% ✓
Portfolio after 10y	$160323633.76M ✓	$28.0K
Annual income after 10y	$138,877,914,359,413.77 ✓	$899.19
Total dividends collected	$158734778.42M ✓	$6.4K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: MDNA vs RYLD ($10,000, DRIP)

Year	MDNA Portfolio	MDNA Income/yr	RYLD Portfolio	RYLD Income/yr	Gap
1← crossover	$138,089	$127,388.54	$11,120	$420.00	+$127.0K → MDNA
2	$1,791,764	$1,644,008.99	$12,357	$458.31	+$1.78M → MDNA
3	$21,853,440	$19,936,252.56	$13,721	$499.76	+$21.84M → MDNA
4	$250,630,524	$227,247,343.53	$15,227	$544.58	+$250.62M → MDNA
5	$2,703,904,938	$2,435,730,277.70	$16,885	$593.02	+$2703.89M → MDNA
6	$27,451,736,905	$24,558,558,620.99	$18,713	$645.34	+$27451.72M → MDNA
7	$262,395,669,533	$233,022,311,044.44	$20,724	$701.81	+$262395.65M → MDNA
8	$2,362,379,104,913	$2,081,615,738,512.96	$22,938	$762.73	+$2362379.08M → MDNA
9	$20,042,728,412,877	$17,514,982,770,620.17	$25,372	$828.41	+$20042728.39M → MDNA
10	$160,323,633,761,192	$138,877,914,359,413.77	$28,047	$899.19	+$160323633.73M → MDNA

MDNA vs RYLD: Complete Analysis 2026

MDNA — Stock

Medicenna Therapeutics Corp., an immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer and other diseases. Its lead product is MDNA55, an interleukin- 4 (IL-4) EC that has completed Phase IIb clinical trial for the treatment of recurrent glioblastoma, as well as preclinical and clinical development stages for the treatment of other brain and non-brain tumors. The company also develops MDNA11, an enhanced version of IL-2 to activate and proliferate the immune cells needed to fight cancer; MDNA209, an IL-2 antagonist for autoimmune diseases, such as multiple sclerosis and graft versus host disease; MDNA413, a dual IL-4/IL-13 antagonist to treat cancer immunotherapies; and MDNA132, an IL-13 Superkine for solid tumors. In addition, it provides BiSKITs platform to develop designer Superkines by fusing them to other proteins, antibodies, cytokines, or other Superkines. The company is headquartered in Toronto, Canada.

Full MDNA Calculator →

RYLD — ETF

RYLD is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in RYLD shares.

Full RYLD Calculator →

📬

Get this MDNA vs RYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MDNA vs SCHD MDNA vs JEPI MDNA vs O MDNA vs KO MDNA vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.